NCT02917512

Efficacy and Safety Study of HU00701/HU007 Eye Drops in Patients With Dry Eye Syndrome

A Multicenter, Placebo Controlled, Restasis® Referenced, Randomized, Double Blind, Phase II Study to Evaluate the Efficacy and Safety of HU00701/HU007 Eye Drops in Patients With Dry Eye Syndrome

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 114 (actual)
• Sponsor: Huons Co., Ltd. · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Accepted

Summary

A multicenter, Placebo controlled, Restasis® referenced, Randomized, Double blind, Phase II Study to Evaluate the Efficacy and Safety of HU00701/HU007 Eye Drops in Adult Patients with Dry Eye Syndrome

Conditions

• Dry Eye Syndrome

Interventions

Type	Name	Description
DRUG	HU00701	Cyclosporine 0.01% + 3% trehalose
DRUG	HU007	Cyclosporine 0.02% + 3% trehalose
DRUG	Restasis	Cyclosporine 0.05%
DRUG	Placebo	Vehicle

Timeline

• Start date: 2016-03-01
• Primary completion: 2016-12-01
• Completion: 2016-12-01
• First posted: 2016-09-28
• Last updated: 2018-04-12

Locations

1 site across 1 country: South Korea